TriangleHEALTH PROFESSIONAL · SOURCE READING
Plexiform Fibrohistiocytic Tumor
Source: Childhood Soft Tissue Sarcoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: April 21, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Context: Treatment of So-Called Fibrohistiocytic Tumors
Plexiform fibrohistiocytic tumor is a rare, low- to intermediate-grade so-called fibrohistiocytic tumor that most commonly affects children and young adults. The median age at presentation ranges from 8 to 14.5 years. However, the tumor has been described in patients as young as 3 months.[1,2]
Continue within this section
Publication references
Read the original reference and check its publication notices.
Preserved source evidence · Not medical advice